Skip to main content
. 2022 Jan 12;40(10):1051–1058. doi: 10.1200/JCO.21.02054

FIG 1.

FIG 1.

CONSORT diagram. CEF, cyclophosphamide and epirubicin plus fluorouracil; CEX, cyclophosphamide and epirubicin plus capecitabine; ITT, intention-to-treat patient population; T, docetaxel; TX, docetaxel plus capecitabine.